MACROmol
PRIVATE
STATUS
Accelerator/Inc
LATEST DEAL TYPE
1
INVESTORS
Description
Developer of a polymeric platform intended to treat tuberculosis. The company's polymeric platform offers a multi-medicine system for nanomedicine innovation to maximize the clinical impact of therapeutics, enabling patients to have fewer drug regimens with improved results.
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Primary Office
- Cambridge
- England, United Kingdom
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore MACROmol’s full profile, request a free trial.
MACROmol Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Apr-2015 | Completed | Startup |
MACROmol Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Accelerate Cambridge | Accelerator/Incubator | 000 0000 | 000000 0 |